Hepatitis B Virus Nucleic Acid Amplification Testing Assay in Detecting Window Period and Occult Hepatitis B Virus Infections in Blood Donors

1. Dodd RY, Notari EP 4th, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;(42):975–9.10.1046/j.1537-2995.2002.00174.xSearch in Google Scholar

2. Niederhauser C, Schneider P, Fopp M, Ruefer A, Lévy G. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Eurosurveillance. 2005;10(2):7-8.10.2807/esm.10.02.00518-enSearch in Google Scholar

3. Zhu HL, Li X, Li J, Zhang ZH. Genetic variation of occult hepatitis B virus infection. World J Gastroenterol. 2016;(22):3531-46.10.3748/wjg.v22.i13.3531Search in Google Scholar

4. Allain JP, Mihaljevic I, Gonzalez-Fraile MI, Gubbe K, Holm-Harritshøj L, Garcia JM et al. Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion. 2013;(53):1405-15.10.1111/trf.12096Search in Google Scholar

5. Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57(3-4):141-50.10.1159/000360947Search in Google Scholar

6. Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. Transfusion-transmitted HBV infection in an endemic area: the necessity for HBV carries. Transfusion. 2002;42(1):592-7.10.1046/j.1537-2995.2002.00274.x12473140Search in Google Scholar

7. Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet. 1999;(353):359-63.10.1016/S0140-6736(98)06318-1Search in Google Scholar

8. Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang. 2012;(102):82-90.10.1111/j.1423-0410.2011.01506.x21933190Search in Google Scholar

9. Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion. 2002;42(12):1592-7.10.1046/j.1537-2995.2002.00274.xSearch in Google Scholar

10. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol. 2005;32(2):102-12.10.1016/j.jcv.2004.10.00815653412Search in Google Scholar

11. Servant-Delmas A, Mercier-Darty M, Ly TD, Wind F, Alloui C, Sureau C, et al. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples. J Clin Virol. 2012;53(4):338-45.10.1016/j.jcv.2012.01.00322296790Search in Google Scholar

12. Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP et al. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang. 2010;98(3p2):403-14.10.1111/j.1423-0410.2009.01272.x286076320412171Search in Google Scholar

13. Olotu AA, Oyelese AO, Salawu, L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J. 2016;13(76).10.1186/s12985-016-0533-3485905827150469Search in Google Scholar

14. Wang Z, Zeng J, Li T, Zheng X, Xu X, Ye X et al. Prevalence of hepatitis B surface antigen (HBsAg) in a blood donor population born prior to and after implementation of universal HBV vaccination in Shenzhen, China. BMC Infect Dis. 2016;(16):498.10.1186/s12879-016-1834-2502896927647214Search in Google Scholar

15. Van der Poel CL, Janssen MP, Behr-Gross ME. The collection, testing and use of blood and blood components in Europe. Directorate for the Quality of Medicines and HealthCare of the Council of Europe (EDQM). 2005.Search in Google Scholar

16. Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection? Transfusion. 2018;58(9):2166-70.10.1111/trf.1478430144082Search in Google Scholar

17. Gou H, Pan Y, Ge H, Zheng Y, Wu Y, Zeng J et al. Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors. Transfusion. 2015;55(9):2272-81.10.1111/trf.1313526177670Search in Google Scholar

18. Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Transfusion. 2014;54(8):2084-91.10.1111/trf.1255624650170Search in Google Scholar

19. Candotti D, Allain JP. Molecular virology in transfusion medicine laboratory. Blood Transfus. 2013;11(2):203-16.Search in Google Scholar

20. Wang L, Chang L, Xie Y, Huang C, Xu L, Qian R et al. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool? Transfusion. 2015;55(2):395-404.10.1111/trf.1281825125223Search in Google Scholar

21. Lelie N, Bruhn R, Busch M, Vermeulen M, Tsoi WC, Kleinman S. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing. Transfusion. 2017;57(1):24-35.10.1111/trf.1381927673757Search in Google Scholar

22. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion. 2003;43(6):788-98.10.1046/j.1537-2995.2003.00424.x12757531Search in Google Scholar

23. Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, Keyter M et al. Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion. 2012;52(4):880-92.10.1111/j.1537-2995.2011.03355.x21981386Search in Google Scholar

24. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology. 2008;49(4):652-7.10.1016/j.jhep.2008.07.01418715666Search in Google Scholar

25. Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H et al. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion. 2013;53(7):1393-404.10.1111/j.1537-2995.2012.03909.x23033944Search in Google Scholar